BioCardia (BCDA) Change in Accured Expenses (2010 - 2026)
BioCardia's (BCDA) quarterly Change in Accured Expenses came in at $20000.0 in Q2 2026, up 195.24% year-over-year from $6774.2 in Q2 2025, and down 89.85% quarter-over-quarter from $197000.0 in Q1 2026.
Powered by 
Analysis
BioCardia (BCDA) Change in Accured Expenses (2010 - 2026) Analysis & Trends
BioCardia (BCDA) has reported Change in Accured Expenses for 16 consecutive years, with $20000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Accured Expenses rose 195.24% year-over-year to $20000.0 in Q2 2026; TTM through Jun 2026 was -$50000.0, a 285.19% decrease from a year earlier, with the FY2025 full-year figure at $179000.0, up 133.27% from the prior year.
- Change in Accured Expenses was $20000.0 for Q2 2026 at BioCardia, down from $197000.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $467000.0 in Q1 2025 and troughed at -$430000.0 in Q2 2024.
- A 5-year average of $42000.0 and a median of $67000.0 in 2022 frame the typical range for Change in Accured Expenses.
- Across the five-year window, Change in Accured Expenses sank 773.91% in 2022 and soared 212.44% in 2023, its largest moves.
- Over 5 years, Change in Accured Expenses stood at $151000.0 in 2022, then tumbled by 176.82% to -$116000.0 in 2023, then soared by 54.31% to -$53000.0 in 2024, then sank by 37.74% to -$73000.0 in 2025, then surged by 127.4% to $20000.0 in 2026.
- The last three Change in Accured Expenses figures came in at $20000.0 (Q2 2026), $197000.0 (Q1 2026), and -$73000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 5.44 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | -5.31 Mn |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | -8.62 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | -9.60 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | 7.17 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | 1.32 Mn |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 7.53 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | 22.70 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 3.68 Mn |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - | 20,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20,000.00 |
| Mar 31, 2026 | 197,000.00 |
| Dec 31, 2025 | -73,000.00 |
| Sep 30, 2025 | -194,000.00 |
| Jun 30, 2025 | -21,000.00 |
| Mar 31, 2025 | 467,000.00 |
| Dec 31, 2024 | -53,000.00 |
| Sep 30, 2024 | -366,000.00 |
| Jun 30, 2024 | -430,000.00 |
| Mar 31, 2024 | 311,000.00 |
| Dec 31, 2023 | -116,000.00 |
| Sep 30, 2023 | 245,000.00 |
| Jun 30, 2023 | 127,000.00 |
| Mar 31, 2023 | 226,000.00 |
| Dec 31, 2022 | 151,000.00 |
| Sep 30, 2022 | 352,000.00 |
| Jun 30, 2022 | 114,000.00 |
| Mar 31, 2022 | -201,000.00 |
| Dec 31, 2021 | 96,000.00 |
| Sep 30, 2021 | 183,000.00 |